Cargando…
COVID-19 Vaccine Pfizer BioNTech: Vogt-Koyanagi-Harada disease exacerbation: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051773/ http://dx.doi.org/10.1007/s40278-022-14095-5 |
Ejemplares similares
-
COVID-19-Vaccine-Pfizer-BioNTech/ciclosporin/mycophenolate sodium: Vogt-Koyanagi-Harada disease reactivation and lack of efficacy: case report
Publicado: (2021) -
Vogt-Koyanagi-Harada Disease Exacerbation Associated with COVID-19 Vaccine
por: De Domingo, Begoña, et al.
Publicado: (2022) -
COVID-19-Vaccine-Pfizer-BioNTech: Thyroiditis: case report
Publicado: (2021) -
COVID-19-Vaccine-Pfizer-BioNTech: Anaphylaxis: case report
Publicado: (2022) -
COVID-19-Vaccine-Pfizer-BioNTech: Myocarditis: case report
Publicado: (2022)